Due to an unprecedented consumer demand for the Shingrix vaccine, any request to purchase this vaccine from healthcare organizations is being placed on backorder status by the manufacturer. At this time, Sindecuse Health Center has depleted our stock of the vaccine. For this reason, we are not able to make appointments to administer the vaccine. This web page will be updated if the situation changes.
Those patients who called for an appointment and were added to the wait list will be contacted in order as the vaccine becomes available. Because we do not know when vaccine supplies will be received, we are no longer adding patients to a wait list. We apologize for any inconvenience this may cause. Community providers are experiencing similar challenges due to the vaccine shortage.
This page will be updated if the situation changes.
When adequate supplies permit, Western Michigan University's Sindecuse Health Center will administer Shingrix, a vaccine to prevent shingles in adults aged 50 years and older.
The new vaccine provides more protection than the previous Zostavax vaccine. Patients receive two doses of the vaccine separated by two to six months. The vaccine may be taken by patients experiencing or recovering from immunosuppression. Sheneeka Skinner, nursing supervisor at the health center says, "Studies have shown this vaccine will be more effective than Zostavax. In fact, the Centers for Disease Control recommends the Shingrix vaccine for individuals who have previously been vaccinated with Zostavax."
Shingrix will be administered at the health center for patients with a clinician's order. WMU employees in the BCBS PPO insurance plan may ask their primary care provider to fax an order for the vaccine to (269) 387-2205. After the order is received, a nursing staff member will call the patient to set up an appointment as supplies allow.
For more information contact health center at (269) 387-3287. For questions regarding insurance coverage call (269) 387-4219.
What Everyone Should Know about Shingles Vaccine (Shingrix) — Centers for Disease Control and Prevention